EUVIMEDEUVIMED entdecken
Open Access

Maternal and Foetal Outcomes of Newly Diagnosed Chronic Myeloid Leukemia During Pregnancy and its Long-Term Impact

Urmimala Bhattacharjee, Charanpreet Singh, Aditya Jandial, K S Lekshmon, Kundan Mishra, Rajeev Sandal, Ram Nampoothiri, Shano Naseem, Vanita Suri, Arihant Jain iD, Deepesh P Lad, Gaurav Prakash und 2 weitere

Indian Journal of Hematology and Blood Transfusion · 2024-10 · 40 (4) · 687-693

DOI: 10.1007/s12288-024-01743-9 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Indian Journal of Hematology and Blood Transfusion, online erschienen am 05.04.2024. Verfasst von Urmimala Bhattacharjee und 13 weiteren Autor:innen. Beteiligte Einrichtung: Department of Clinical Haematology and Medical Oncology, Postgraduate Institute of Medical Education and Research, Chandigarh, 160012 India. Die Arbeit wurde bisher 7-mal zitiert (Crossref) und nennt 28 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Diagnosing Chronic Myeloid Leukemia (CML) during pregnancy presents challenges for both haematologists and obstetricians. Limited data exists regarding the management of pregnancy-associated CML in low- and middle-income countries (LMICs). This study aimed to assess pregnancy, foetal, and long-term disease outcomes in female patients newly diagnosed with CML in the chronic phase (CML-CP) during pregnancy. A retrospective analysis was conducted on female CML-CP patients presenting between January 2002 and December 2022 at our institution. Inclusion criteria encompassed patients newly diagnosed with CML-CP during pregnancy. Data pertaining to pregnancy outcomes, foetal development, and disease progression were analysed through a comprehensive review of medical records. Among the female CML patients, thirteen were diagnosed with CML-CP during pregnancy. The median patient age was 24 years (range: 20-35). Diagnoses occurred in the first trimester for six patients, the second trimester for three, and the third trimester for four. Outcomes included five elective terminations (38.5%), five pre-term deliveries (38.5%), and three full-term deliveries (23.1%). Management included observation in 6 (46.3%), hydroxyurea in 3 (23.1%), imatinib in 3 (23.1%) and Interferon-α (IFN-α) in 1 (7.7%) patients. Noteworthy obstetric complications encompassed threatened abortion with intrauterine foetal death (IUFD) (1 patient), intrauterine growth retardation (IUGR) (3 patients), oligohydramnios (2 patients), antepartum haemorrhage (1 patient), placental abruption (1 patient), and postpartum haemorrhage (3 patients). At a median follow-up duration of 10.7 years, 11 patients were at a major molecular remission (including 2 patients with deep molecular remission) and two patients progressed to the accelerated phase. The diagnosis and management of CML during pregnancy is a complex and challenging task that requires collaboration between haematologists and obstetricians. Effective management of newly diagnosed CML-CP during pregnancy is contingent on the trimester of presentation. Further research and collaboration are warranted to develop standardised guidelines for managing pregnancy-associated CML, particularly in LMICs.

Schlagwörter

Stichwörter der Autor:innen

Chronic myeloid leukemiaLow-and-middle-income countriesObstetric complicationsPregnancy

Autor:innen und Institutionen

  • Department of Clinical Haematology and Medical Oncology, Postgraduate Institute of Medical Education and Research, Chandigarh, 160012 India.
  • Department of Haematology, Postgraduate Institute of Medical Education and Research, Chandigarh, India.
  • Department of Obstetrics and Gynaecology, Postgraduate Institute of Medical Education and Research, Chandigarh, India.

ORCID-Profile: Arihant Jain, Pankaj Malhotra

Zitieren

APA

Bhattacharjee, U., Singh, C., Jandial, A., Lekshmon, K. S., Mishra, K., Sandal, R., Nampoothiri, R., Naseem, S., Suri, V., Jain, A., Lad, D. P., Prakash, G., Khadwal, A., & Malhotra, P. (2024). Maternal and Foetal Outcomes of Newly Diagnosed Chronic Myeloid Leukemia During Pregnancy and its Long-Term Impact. Indian Journal of Hematology and Blood Transfusion, 40(4), 687-693. https://doi.org/10.1007/s12288-024-01743-9

Vancouver

Bhattacharjee U, Singh C, Jandial A, Lekshmon KS, Mishra K, Sandal R, et al. Maternal and Foetal Outcomes of Newly Diagnosed Chronic Myeloid Leukemia During Pregnancy and its Long-Term Impact. Indian Journal of Hematology and Blood Transfusion. 2024;40(4):687-693. doi:10.1007/s12288-024-01743-9

BibTeX
@article{Bhattacharjee2024,
  author = {Bhattacharjee, Urmimala and Singh, Charanpreet and Jandial, Aditya and Lekshmon, K S and Mishra, Kundan and Sandal, Rajeev and Nampoothiri, Ram and Naseem, Shano and Suri, Vanita and Jain, Arihant and Lad, Deepesh P and Prakash, Gaurav and Khadwal, Alka and Malhotra, Pankaj},
  title = {Maternal and Foetal Outcomes of Newly Diagnosed Chronic Myeloid Leukemia During Pregnancy and its Long-Term Impact},
  journal = {Indian Journal of Hematology and Blood Transfusion},
  year = {2024},
  volume = {40},
  number = {4},
  pages = {687--693},
  doi = {10.1007/s12288-024-01743-9}
}
Kostenlos starten →